Pay attention to the development of cross-linking technology and the potential application value of scleral cross-linking technology in controlling myopia development

doi:10.3877/cma.j.issn.2095-2007.2023.02.001

Abstract

Abstract:

Myopia is one of the common causes of visual impairment, and pathological myopia, due to the reshaping of the sclera structure, also involves changes in the eye structure in addition to abnormal refractive status. In recent years, methods to control the development of myopia have been explored, and the method of enhancing scleral strength through cross-linking technology has been paid more attention. Crosslinking technology includes physical methods and chemical methods. At present, the most commonly used method is ultraviolet Riboflavin crosslinking. As a previously mature method for the treatment of various corneal diseases, understanding scleral cross-linking technology using enhancing scleral strength provides important ideas for the control of myopia development. In this paper, the research and application of scleral cross-linking technology in controlling the development of myopia were reviewed in recent years.

Key words: Myopia, Crosslinking, Sclera, Cornea

Yu Cao, Zequn Miao, Kai Wang, Lejin Wang. Pay attention to the development of cross-linking technology and the potential application value of scleral cross-linking technology in controlling myopia development[J]. Chinese Journal of Ophthalmologic Medicine(Electronic Edition), 2023, 13(02): 65-69.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhykyxzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-2007.2023.02.001

https://zhykyxzz.cma-cmc.com.cn/EN/Y2023/V13/I02/65

References 56

[1]	Kumar A, Chawla R, Kumawat D, et al. Insight into high myopia and the macula[J]. Indian J Ophthalmol, 2017, 65(2): 85－91.
[2]	Chan NS, Teo K, Cheung CM. Epidemiology and Diagnosis of Myopic Choroidal Neovascularization in Asia[J]. Eye Contact Lens, 2016, 42(1): 48－55.
[3]	Wenbo L, Congxia B, Hui L. Genetic and environmental－genetic interaction rules for the myopia based on a family exposed to risk from a myopic environment[J]. Gene, 2017, 626: 305－308.
[4]	Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet－a－induced collagen crosslinking for the treatment of keratoconus[J]. Am J Ophthalmol, 2003, 135(5): 620－627.
[5]	Raiskup F, Spoerl E. Corneal crosslinking with riboflavin and ultraviolet A. I. Principles[J]. Ocul Surf., 2013, 11(2): 65－74.
[6]	Seiler TG, Komninou MA, Nambiar MH, et al. Oxygen Kinetics During Corneal Cross－linking With and Without Supplementary Oxygen[J]. Am J Ophthalmol, 2021, 223: 368－376.
[7]	Huang R, Choe E, Min DB. Kinetics for singlet oxygen formation by riboflavin photosensitization and the reaction between riboflavin and singlet oxygen[J]. J Food Sci, 2004, 69: 726－732.
[8]	Kamaev P, Friedman MD, Sherr E, et al. Photochemical kinetics of corneal cross－linking with riboflavin[J]. Invest Ophthalmol Vis Sci, 2012, 53(4): 2360－2367.
[9]	Cifariello F, Minicucci M, Di Renzo F, et al. Epi－Off versus Epi－On Corneal Collagen Cross－Linking in Keratoconus Patients: A Comparative Study through 2－Year Follow－Up[J]. J Ophthalmol, 2018: 4947983.
[10]	Abdel－Radi M, Eldaly Z, Abdelmotaal H, et al. Correlation between corneal demarcation line depth in epithelium－off and trans－epithelium accelerated corneal cross linking and keratoconus progression[J]. Int J Ophthalmol, 2020, 13(6): 907－912.
[11]	Bradford S, Mikula E, Xie Y, et al. Enhanced Transepithelial Riboflavin Delivery Using Femtosecond Laser－Machined Epithelial Microchannels[J]. Transl Vis Sci Technol, 2020, 9(6): 1.
[12]	Hayes S, Morgan SR, O'Brart DP, et al. A study of stromal riboflavin absorption in ex vivo porcine corneas using new and existing delivery protocols for corneal cross－linking[J]. Acta Ophthalmol, 2016, 94(2): e109－e117.
[13]	Aldahlawi NH, Hayes S, O'Brart DPS, et al. An investigation into corneal enzymatic resistance following epithelium－off and epithelium－on corneal cross－linking protocols[J]. Exp Eye Res, 2016, 153: 141－151.
[14]	Rong S, Wang C, Han B, et al. Iontophoresis－assisted accelerated riboflavin/ultraviolet A scleral cross－linking: A potential treatment for pathologic myopia[J]. Exp Eye Res, 2017, 162: 37－47.
[15]	Cassagne M, Laurent C, Rodrigues M, et al. Iontophoresis Transcorneal Delivery Technique for Transepithelial Corneal Collagen Crosslinking With Riboflavin in a Rabbit Model[J]. Invest Ophthalmol Vis Sci, 2016, 57(2): 594－603.
[16]	Vinciguerra P, Mencucci R, Romano V, et al. Imaging mass spectrometry by matrix assisted laser desorption/ionization and stress－strain measurements in iontophoresis transepithelial corneal collagen cross－linking[J]. Biomed Res Int, 2014: 404587.
[17]	Caruso C, Ostacolo C, Epstein RL, et al. Transepithelial Corneal Cross－Linking With Vitamin E－Enhanced Riboflavin Solution and Abbreviated, Low－Dose UV－A: 24－Month Clinical Outcomes[J]. Cornea, 2016, 35(2): 145－150.
[18]	Wollensak G, Iomdina E. Long－term biomechanical properties after collagen crosslinking of sclera using glyceraldehyde[J]. Acta Ophthalmol, 2008, 86(8): 887－893.
[19]	Liu TX, Luo X, Gu YW, et al. Correlation of discoloration and biomechanical properties in porcine sclera induced by genipin[J]. Int J Ophthalmol, 2014, 7(4): 621－625.
[20]	Wong FF, Lari DR, Schultz DS, et al. Whole globe inflation testing of exogenously crosslinked sclera using genipin and methylglyoxal[J]. Exp Eye Res, 2012, 103: 17－21.
[21]	Babar N, Kim M, Cao K, et al. Cosmetic preservatives as therapeutic corneal and scleral tissue cross－linking agents[J]. Invest Ophthalmol Vis Sci, 2015, 56(2): 1274－1282.
[22]	Kobashi H, Rong SS. Corneal Collagen Cross－Linking for Keratoconus: Systematic Review[J]. Biomed Res Int, 2017: 8145651.
[23]	Hersh PS, Stulting RD, Muller D, et al. U．S. Multicenter Clinical Trial of Corneal Collagen Crosslinking for Treatment of Corneal Ectasia after Refractive Surgery[J]. Ophthalmology, 2017, 124(10): 1475－1484.
[24]	Lim EWL, Lim L. Review of Laser Vision Correction (LASIK, PRK and SMILE) with Simultaneous Accelerated Corneal Crosslinking－Long－term Results[J]. Curr Eye Res, 2019, 44(11): 1171－1180.
[25]	Seven I, Sinha Roy A, Dupps WJ, et al. Patterned corneal collagen crosslinking for astigmatism: computational modeling study[J]. J Cataract Refract Surg, 2014, 40(6): 943－953.
[26]	Bettis DI, Hsu M, Moshirfar M. Corneal collagen cross－linking for nonectatic disorders: a systematic review[J]. J Refract Surg, 2012, 28(11): 798－807.
[27]	Ting DSJ, Henein C, Said DG, et al. Photoactivated chromophore for infectious keratitis － Corneal cross－linking (PACK－CXL): A systematic review and meta－analysis[J]. Ocul Surf, 2019, 17(4): 624－634.
[28]	Downs JC, Roberts MD, Burgoyne CF. Mechanical environment of the optic nerve head in glaucoma[J]. Optom Vis Sci, 2008, 85(6): 425－435.
[29]	Thornton IL, Dupps WJ, Sinha RA, et al. Biomechanical effects of intraocular pressure elevation on optic nerve/lamina cribrosa before and after peripapillary scleral collagen cross－linking[J]. Invest Ophthalmol Vis Sci, 2009, 50(3): 122733.
[30]	Korneva A, Nguyen C, Schaub J, et al. Biomechanical effects on the mouse optic nerve head in experimental scleral crosslinking in glaucoma[J]. Invest Ophthalmol Vis Sci, 2019, 60(9): 6188.
[31]	Wollensak G, Spoerl E. Collagen crosslinking of human and porcine sclera[J]. J Cataract Refract Surg, 2004, 30(3): 689－695.
[32]	Dotan A, Kremer I, Livnat T, et al. Scleral cross－linking using riboflavin and ultraviolet－a radiation for prevention of progressive myopia in a rabbit model[J]. Exp Eye Res, 2014, 127: 190－195.
[33]	Wollensak G, Iomdina E, Dittert DD, et al. Cross－linking of scleral collagen in the rabbit using riboflavin and UVA[J]. Acta Ophthalmol Scand, 2005, 83(4): 477－482.
[34]	Jung GB, Lee HJ, Kim JH, et al. Effect of cross－linking with riboflavin and ultraviolet A on the chemical bonds and ultrastructure of human sclera[J]. J Biomed Opt, 2011, 16(12): 125004.
[35]	Choi S, Lee SC, Lee HJ, et al. Structural response of human corneal and scleral tissues to collagen cross－linking treatment with riboflavin and ultraviolet A light[J]. Lasers Med Sci, 2013, 28(5): 1289－1296.
[36]	Zhang M, Zou Y, Zhang F, et al. Efficacy of Blue－Light Cross－linking on Human Scleral Reinforcement[J]. Optom Vis Sci, 2015, 92(8): 873－878.
[37]	Li Y, Liu C, Sun M, et al. Ocular safety evaluation of blue light scleral cross－linking in vivo in rhesus macaques[J]. Graefes Arch Clin Exp Ophthalmol, 2019, 257(7): 1435－1442.
[38]	Wang M, Zhang F, Liu K, et al. Safety evaluation of rabbit eyes on scleral collagen cross－linking by riboflavin and ultraviolet A[J]. Clin Exp Ophthalmol, 2015, 43(2): 156－163.
[39]	Lv Y, Zhou H, Xia W, et al. Effect of ultraviolet A (UVA) plus riboflavin induced collagen cross－linking on biomechanical properties of the sclera in guinea pigs[J]. Acta Lab Anim Sci Sin, 2012, 20: 44－47.
[40]	Gawargious BA, Le A, Lesgart M, et al. Differential Regional Stiffening of Sclera by Collagen Cross linking[J]. Curr Eye Res, 2020, 45(6): 718－725.
[41]	Sun M, Zhang F, Li Y, et al. Evaluation of the Safety and Long－term Scleral Biomechanical Stability of UVA Cross－linking on Scleral Collagen in Rhesus Monkeys[J]. J Refract Surg, 2020, 36(10): 696－702.
[42]	Gawargious BA, Le A, Lesgart M, et al. Differential Regional Stiffening of Sclera by Collagen Cross linking[J]. Curr Eye Res, 2020, 45(6): 718－725.
[43]	Karl A, Makarov FN, Koch C, et al. The ultrastructure of rabbit sclera after scleral crosslinking with riboflavin and blue light of different intensities[J]. Graefes Arch Clin Exp Ophthalmol, 2016, 254(8): 1567－1577.
[44]	Kwok SJJ, Kim M, Lin HH, et al. Flexible Optical Waveguides for Uniform Periscleral Cross Linking[J]. Invest Ophthalmol Vis Sci, 2017, 58(5): 2596－2602.
[45]	Xiao B, Chu Y, Wang H, et al. Minimally Invasive Repetitive UVA Irradiation along with Riboflavin Treatment Increased the Strength of Sclera Collagen Cross－Linking[J]. J Ophthalmol, 2017: 1324012.
[46]	Kwok SJJ, Forward S, Wertheimer CM, et al. Selective Equatorial Sclera Crosslinking in the Orbit Using a Metal－Coated Polymer Waveguide[J]. Invest Ophthalmol Vis Sci, 2019, 60(7): 2563－2570.
[47]	Rong S, Wang C, Han B, et al. Iontophoresis－assisted accelerated riboflavin/ultraviolet A scleral cross－linking: A potential treatment for pathologic myopia[J]. Exp Eye Res, 2017, 162: 37－47.
[48]	Li X, Wu M, Zhang L, et al. Riboflavin and ultraviolet A irradiation for the prevention of progressive myopia in a guinea pig model[J]. Exp Eye Res, 2017, 165：1－6.
[49]	Levy AM, Fazio MA, Grytz R. Experimental myopia increases and scleral crosslinking using genipin inhibits cyclic softening in the tree shrew sclera[J]. Ophthalmic Physiol Opt, 2018, 38(3): 246－256.
[50]	Metzler KM, Roberts CJ, Mahmoud AM, et al. Ex Vivo Transepithelial Collagen Cross－linking in Porcine and Human Corneas Using Human Decorin Core Protein[J]. J Refract Surg, 2016, 32(6): 410－417.
[51]	Kimball EC, Nguyen C, Steinhart MR, et al, Pease ME, Oglesby EN, et al. Experimental scleral cross－linking increases glaucoma damage in a mouse model[J]. Exp Eye Res, 2014, 128: 129－140.
[52]	Lin X, Naidu RK, Dai J, et al. Scleral Cross－Linking Using Glyceraldehyde for the Prevention of Axial Elongation in the Rabbit: Blocked Axial Elongation and Altered Scleral Microstructure[J]. Curr Eye Res, 2019, 44(2): 162－171.
[53]	Xue A, Zheng L, Tan G, et al. Genipin－Crosslinked Donor Sclera for Posterior Scleral Contraction/Reinforcement to Fight Progressive Myopia[J]. Invest Ophthalmol Vis Sci, 2018, 59(8): 3564－3573.
[54]	Gupta P, Yadav KS. Applications of microneedles in delivering drugs for various ocular diseases[J]. Life Sci, 2019, 237: 116907.
[55]	Zhou C, Robert MC, Kapoulea V, et al. Sustained Subconjunctival Delivery of Infliximab Protects the Cornea and Retina Following Alkali Burn to the Eye[J]. Invest Ophthalmol Vis Sci, 2017, 58(1): 96－105.
[56]	Perez VL, Wirostko B, Korenfeld M, et al. Ophthalmic Drug Delivery Using Iontophoresis: Recent Clinical Applications[J]. J Ocul Pharmacol Ther, 2020, 36(2): 75－87.

Please choose a citation manager

Content to export